Oncology Ventures LLC
oncology.ventures Exempt reporting adviser
Oncology Ventures LLC reports 11 venture funds on Form ADV among 11 private funds, with $81M in gross private fund assets.
The numbers
| Began raising | Raised |
|---|---|
| 2023 | $40M |
| 2024 | $5M |
| 2026 | $42M |
| 2026 | $12M |
Updates from Oncology Ventures LLC
Funds on Form D
Venture funds whose Form D filings carry this adviser’s name, matched by name. Amounts are what each fund last reported to the SEC.
| Fund | Began raising | Target | Raised | Investors | Latest filing |
|---|---|---|---|---|---|
| Oncology Ventures Fund II LP | 2026 | $70M | $42M | 99 | March 19, 2026 |
| Oncology Ventures Fund II-A LP | 2026 | $70M | $12M | 50 | March 19, 2026 |
| Oncology Ventures Fund I-A LP | 2024 | Not stated | $5M | 37 | May 14, 2024 |
| Oncology Ventures Fund I LP | 2023 | $40M | $40M | 69 | May 14, 2024 |
LPs on the record
No foundation or public plan in the reports we read names this adviser’s funds yet. Find LPs that back firms like it: name a few peers and Hottub ranks the LPs that hold their funds.
Registration
- Legal name
- Oncology Ventures LLC
- Status
- Exempt reporting adviser since February 10, 2025
- CRD number
- 334395
Full Form ADV on the SEC’s Investment Adviser Public Disclosure site
About this data
Registered and exempt reporting advisers that report managing at least one venture capital fund on Form ADV, with the number of private funds and their gross assets as each adviser reports them. Advisers whose business name reads as an individual's are left out. From the roster published for September 2026. Source. Benchmarks for funds like these are in Raise benchmarks.
Share this page
For a post, a deck, or a note to your partners: image (PNG) · vector (SVG).
